A mean increase in HR of 1.86 beats/min was reported in a meta-analysis including available data from randomized controlled trials testing GLP-1 agonists against placebo in patients with T2D [53]
In October 2024, Novo Nordisk formally asked the FDA to ban the production of compounded semaglutide and requested that the agency move the drug to its Demonstrable Difficulties for Compounding (DDC) list
Rest assured, Burns & Wilcox through its global footprint, with teams around the world, is prepared to immediately adapt to these changes to address your specialty P&C needs
Depression is a disease that is highly related to neuroinflammation, neurotransmitter imbalance, blood-brain barrier hyperpermeability, deficits in neurogenesis, and synaptic dysfunction (Najjar et al., 2013
In particular, the association between DM [1] , prediabetes [12] and male hypogonadism has been largely claimed and proven
Regulation of inflammation by short chain fatty acids